(Q73287848)
Statements
A phase II trial of docetaxel (Taxotere) in hormone-refractory prostate cancer: correlation of antitumor effect to phosphorylation of Bcl-2 (English)
D Friedland
J Cohen
R Miller
M Voloshin
R Gluckman
B Lembersky
B Zidar
M Keating
N Reilly
1 October 1999